Alpha Tau Medical Ltd. Research and Development in Process
Alpha Tau Medical Ltd. (DRTS) reported Research and Development in Process of $4.29 million for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2023-03-09
| Period end | Research and Development in Process 1 month | Research and Development in Process 12 month |
|---|---|---|
| 2022-12-31 | $4.29M 20-F · filed 2023-03-09 | |
| 2021-12-31 | $654.00K 20-F · filed 2023-03-09 | |
| 2020-12-31 | $372.00K 20-F · filed 2023-03-09 |